This observational analysis examines outcomes of pancreatic neuroendocrine neoplasms surgery, suggesting blood transfusion may negatively impact recovery and prognosis.
Introduction: Pancreatic neuroendocrine neoplasms (pNEN) are a rare and heterogeneous group of tumors, whose diagnosis, treatment, and research are particularly challenging due to their rarity and biological diversity. While surgical resection remains the primary curative approach for patients with resectable pNEN, the influence of perioperative blood transfusion on surgical and oncological outcomes in this patient population is not well understood.
No takes yet. Share an insight, caveat, or question.
Lewosinska et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: